Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehboob Hoque

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Scientific Reports|April 11, 2025
Immunoinformatics based designing of a multi-epitope cancer vaccine targeting programmed cell death ligand 1Syed Sahajada Mahafujul Alam, Showkat Ahmad Mir, Arijit Samanta, et al.
Molecules (Basel, Switzerland)|August 12, 2022
Targeting Glutaminase by Natural Compounds: Structure-Based Virtual Screening and Molecular Dynamics Simulation Approach to Suppress Cancer ProgressionShams Tabrez, Torki A Zughaibi, Mehboob Hoque, et al.
Neuroscience and Biobehavioral Reviews|November 26, 2022
Nanomedicine-based immunotherapy for Alzheimer's diseaseMehboob Hoque, Arijit Samanta, Syed Sahajada Mahafujul Alam, et al.
International Journal of Biological Macromolecules|February 28, 2024
Identification and functional characterization of putative ligand binding domain(s) of JlpA protein of Campylobacter jejuniChandan Gorain, Subhadeep Gupta, S S Mahafujul Alam, et al.
Journal of Cellular Biochemistry|January 12, 2024
Nonsynonymous mutations in VEGF receptor binding domain alter the efficacy of bevacizumab treatmentAshif Ahamed, Arijit Samanta, Syed Sahajada Mahafujul Alam, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|February 24, 2022
Elucidating Antiangiogenic Potential of <i>Rauwolfia serpentina</i>: VEGFR-2 Targeting-Based Molecular Docking StudyAdel M Abuzenadah, Fatin Al-Sayes, Syed Sahajada Mahafujul Alam, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|April 4, 2022
Identification of Potential Poly (ADP-Ribose) Polymerase-1 Inhibitors Derived from <i>Rauwolfia serpentina</i>: Possible Implication in Cancer TherapyAdel M Abuzenadah, Fatin Al-Sayes, Syed Sahajada Mahafujul Alam, et al.
Current Pharmaceutical Design|November 29, 2023
Non-synonymous Single Nucleotide Polymorphisms in Human <i>ACE2</i> Gene May Affect the Infectivity of SARS-CoV-2 Omicron SubvariantsArijit Samanta, Ashif Ahamed, Syed Sahajada Mahafujul Alam, et al.
Cells|October 27, 2022
Analysis of the Compositional Features and Codon Usage Pattern of Genes Involved in Human AutophagyZarnain Jamil, Arif Uddin, Syed Sahajada Mahafujul Alam, et al.
Pharmacological Research|December 7, 2020
Prospective therapeutic potential of Tanshinone IIA: An updated overviewMohammad Azam Ansari, Farheen Badrealam Khan, Haaris Ahsan Safdari, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Scientific Reports|April 11, 2025
Immunoinformatics based designing of a multi-epitope cancer vaccine targeting programmed cell death ligand 1Syed Sahajada Mahafujul Alam, Showkat Ahmad Mir, Arijit Samanta, et al.
Molecules (Basel, Switzerland)|August 12, 2022
Targeting Glutaminase by Natural Compounds: Structure-Based Virtual Screening and Molecular Dynamics Simulation Approach to Suppress Cancer ProgressionShams Tabrez, Torki A Zughaibi, Mehboob Hoque, et al.
Neuroscience and Biobehavioral Reviews|November 26, 2022
Nanomedicine-based immunotherapy for Alzheimer's diseaseMehboob Hoque, Arijit Samanta, Syed Sahajada Mahafujul Alam, et al.
International Journal of Biological Macromolecules|February 28, 2024
Identification and functional characterization of putative ligand binding domain(s) of JlpA protein of Campylobacter jejuniChandan Gorain, Subhadeep Gupta, S S Mahafujul Alam, et al.
Journal of Cellular Biochemistry|January 12, 2024
Nonsynonymous mutations in VEGF receptor binding domain alter the efficacy of bevacizumab treatmentAshif Ahamed, Arijit Samanta, Syed Sahajada Mahafujul Alam, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|February 24, 2022
Elucidating Antiangiogenic Potential of <i>Rauwolfia serpentina</i>: VEGFR-2 Targeting-Based Molecular Docking StudyAdel M Abuzenadah, Fatin Al-Sayes, Syed Sahajada Mahafujul Alam, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|April 4, 2022
Identification of Potential Poly (ADP-Ribose) Polymerase-1 Inhibitors Derived from <i>Rauwolfia serpentina</i>: Possible Implication in Cancer TherapyAdel M Abuzenadah, Fatin Al-Sayes, Syed Sahajada Mahafujul Alam, et al.
Current Pharmaceutical Design|November 29, 2023
Non-synonymous Single Nucleotide Polymorphisms in Human <i>ACE2</i> Gene May Affect the Infectivity of SARS-CoV-2 Omicron SubvariantsArijit Samanta, Ashif Ahamed, Syed Sahajada Mahafujul Alam, et al.
Cells|October 27, 2022
Analysis of the Compositional Features and Codon Usage Pattern of Genes Involved in Human AutophagyZarnain Jamil, Arif Uddin, Syed Sahajada Mahafujul Alam, et al.
Pharmacological Research|December 7, 2020
Prospective therapeutic potential of Tanshinone IIA: An updated overviewMohammad Azam Ansari, Farheen Badrealam Khan, Haaris Ahsan Safdari, et al.
Pageof 5